mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |